| Name | Etigilimab |
|---|
| Description | Etigilimab (OMP-313M32), a humanized IgG1 monoclonal antibody, blocks TIGIT interaction with PVR (CD155; poliovirus receptor) and inhibits downstream signalling with target cell killing[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |